Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Buy
55
MNST Quote, Financials, Valuation and Earnings
Last price:
$59.9900
Seasonality move
:
10.33%
Day range:
$59.8900 - $60.7700
52-week range:
$43.3200 - $61.2900
Dividend yield:
0%
P/E ratio:
38.31x
P/S ratio:
8.24x
P/B ratio:
9.95x
Volume:
4.5M
Avg. volume:
5.9M
1-year change:
10.75%
Market cap:
$59.3B
Revenue:
$7.5B
EPS (TTM):
$1.59
Analysts' Opinion
-
Consensus RatingMonster Beverage has received a consensus rating of Hold. The company's average rating is a Hold based on 9 Buy ratings, 10 Hold ratings, and 1 Sell rating.
-
Price Target DownsideAccording to analysts' consensus price target of $59.0178, Monster Beverage has an estimated downside of -3.11% from its current price of $60.9100.
-
Price Target UpsideAccording to analysts, the highest upside price target is $71.0000 representing 16.57% upside increase from its current price of $60.9100.
Fair Value
-
According to the consensus of 20 analysts, Monster Beverage has -3.11% downside to fair value with a price target of $59.0178 per share.
MNST vs. S&P 500
-
Over the past 5 trading days, Monster Beverage has overperformed the S&P 500 by 2.64% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Monster Beverage does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Monster Beverage has grown year-over-year revenues for 18 quarters straight. In the most recent quarter Monster Beverage reported revenues of $1.8B.
Earnings Growth
-
Monster Beverage has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Monster Beverage reported earnings per share of $0.38.
Enterprise value:
58.1B
EV / Invested capital:
--
Price / LTM sales:
8.24x
EV / EBIT:
30.11x
EV / Revenue:
7.76x
PEG ratio (5yr expected):
14.84x
EV / Free cash flow:
35.83x
Price / Operating cash flow:
38.04x
Enterprise value / EBITDA:
28.90x
Gross Profit (TTM):
$4B
Return On Assets:
17.3%
Net Income Margin (TTM):
20.14%
Return On Equity:
21.93%
Return On Invested Capital:
20.8%
Operating Margin:
21.04%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $6.3B | $7.1B | $7.5B | $1.7B | $1.8B | |
| Gross Profit | $3.2B | $3.8B | $4B | $938.4M | $1B | |
| Operating Income | $1.6B | $2B | $1.9B | $434M | $381.2M | |
| EBITDA | $1.6B | $2B | $2B | $452.5M | $401.8M | |
| Diluted EPS | $1.12 | $1.55 | $1.59 | $0.35 | $0.38 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3.1B | $4.7B | $4.8B | $5.6B | $3.6B | |
| Total Assets | $6.2B | $7.8B | $8.3B | $9.7B | $7.7B | |
| Current Liabilities | $750M | $965.1M | $1B | $1.2B | $1.1B | |
| Total Liabilities | $1B | $1.2B | $1.3B | $1.5B | $1.8B | |
| Total Equity | $5.2B | $6.6B | $7B | $8.2B | $6B | |
| Total Debt | -- | -- | -- | -- | $374M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $887.7M | $1.7B | $1.9B | $434.3M | $461.7M | |
| Cash From Investing | -$161.4M | -$193.4M | $733.7M | $166.6M | -$109.3M | |
| Cash From Financing | -$706.9M | -$542.6M | -$3.3B | -$108.8M | -$361.3M | |
| Free Cash Flow | $675.5M | $1.5B | $1.6B | $318.9M | $349.5M | |
MNST
Sector
Market Cap
$59.3B
$257.3M
Price % of 52-Week High
99.38%
73.99%
Dividend Yield
0%
0%
Shareholder Yield
7.07%
3.16%
1-Year Price Total Return
10.75%
-10.07%
Beta (5-Year)
0.629
0.395
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$59.4500
200-day SMA
Buy
Level
$52.4325
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$58.5925
Relative Strength Index (RSI14)
Buy
Level
58.7033
ADX Line
Neutral
Level
0
Williams %R
Sell
Level
-8.8681
50-day SMA
Buy
Level
$56.9820
MACD (12, 26)
Buy
Level
0.9169
25-day Aroon Oscillator
Buy
Level
68
On Balance Volume
Neutral
Level
--
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (20.9646)
Buy
CA Score
(Annual)
Level (2.3193)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-4.7755)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Monster Beverage is a leader in the energy drink category within the nonalcoholic ready-to-drink beverage market, generating two thirds of revenue in the US and Canada. The well-known Monster trademark includes brands such as Monster Energy, Monster Ultra, Java Monster, and Juice Monster. The firm also owns other energy drink brands, such as Reign, NOS, Burn, Bang and Mother, and brews and distributes beers and flavored malt beverages following the acquisition of a craft brewer in 2022. Monster controls branding and innovation but outsources beverage manufacturing and packaging to copackers and finished goods distribution to bottlers in the global Coca-Cola system (pursuant to a 20-year agreement inked in 2015). Coke is the largest shareholder of Monster with a 19.5% stake.
Stock Forecast FAQ
In the current month, MNST has received 9 Buy ratings 10 Hold ratings, and 1 Sell ratings. The MNST average analyst price target in the past 3 months is $59.0178.
-
Where Will Monster Beverage Stock Be In 1 Year?
According to analysts, the consensus estimate is that Monster Beverage share price will drop to $59.0178 per share over the next 12 months.
-
What Do Analysts Say About Monster Beverage?
Analysts are divided on their view about Monster Beverage share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Monster Beverage is a Sell and believe this share price will rise from its current level to $47.0000.
-
What Is Monster Beverage's Price Target?
The price target for Monster Beverage over the next 1-year time period is forecast to be $59.0178 according to 20 Wall Street analysts, 9 of them rate the stock a Buy, 1 rates the stock a Sell, and 10 analysts rate the stock a Hold.
-
Is MNST A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Monster Beverage is a Hold. 10 of 20 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of MNST?
You can purchase shares of Monster Beverage via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Monster Beverage shares.
-
What Is The Monster Beverage Share Price Today?
Monster Beverage was last trading at $59.9900 per share. This represents the most recent stock quote for Monster Beverage. Yesterday, Monster Beverage closed at $60.9100 per share.
-
How To Buy Monster Beverage Stock Online?
In order to purchase Monster Beverage stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 6
Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.
Buy
63
SKX alert for May 6
Skechers USA [SKX] is down 0.07% over the past day.
Sell
20
PTCT alert for May 6
PTC Therapeutics [PTCT] is down 11% over the past day.
